We are live on
!
Find out more
TCM
Tran Capital Management Portfolio holdings
AUM
$869M
1-Year Est. Return
52.91%
This Fund
S&P 500
This Quarter
Est. Return
+22.6%
1 Year Est. Return
+52.91%
3 Year Est. Return
+148.95%
5 Year Est. Return
+156.56%
10 Year Est. Return
+751.84%
AUM
$590M
AUM Growth
+$14.6M
(+2.5%)
Cap. Flow
-$107M
Cap. Flow
% of AUM
-18.09%
Top 10 Holdings %
Top 10 Hldgs %
56.54%
Holding
45
New
3
Increased
4
Reduced
20
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aon
AON
|
+$11.5M |
| 2 |
Elanco Animal Health
ELAN
|
+$10.3M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$7.1M |
| 4 |
Guidewire Software
GWRE
|
+$6.91M |
| 5 |
Equinix
EQIX
|
+$5.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keysight
KEYS
|
+$23.9M |
| 2 |
Autodesk
ADSK
|
+$22.6M |
| 3 |
Meta Platforms (Facebook)
META
|
+$18.4M |
| 4 |
CELG
Celgene Corp
CELG
|
+$9.37M |
| 5 |
IQVIA
IQV
|
+$9.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.77% |
| 2 | Communication Services | 15.3% |
| 3 | Industrials | 13.83% |
| 4 | Technology | 13.46% |
| 5 | Financials | 12.7% |
Similar funds
ICCFIA
BGC
PLFA
HP
RWA
WCM
RWM
EI
Tran Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Tran Capital Management held 45 positions worth $590M, up 2.5% from $576M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Tran Capital Management withdrew a net $107M in Q1 2019, closing 10 positions and reducing 20 holdings. Its most notable exit was Celgene Corp, an estimated $9.37M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Communication Services and Industrials.
Against the trend, Tran Capital Management opened a new position in Aon worth $12.1M.
- Tran Capital Management's largest Q1 2019 buy was Aon: 70,794 shares worth $12.1M.
- Tran Capital Management added most to Anadarko Petroleum in Q1 2019, an estimated $7.1M increase.
- Tran Capital Management's biggest Q1 2019 reduction was Keysight, cutting an estimated $23.9M.
- Tran Capital Management fully exited Celgene Corp in Q1 2019, selling an estimated $9.37M.
- Tran Capital Management's ten largest holdings make up 57% of its $590M portfolio in Q1 2019.
- Tran Capital Management opened 3 new positions and closed 10 in Q1 2019.
- Tran Capital Management's portfolio value rose 2.5% quarter-over-quarter to $590M.
Based on Tran Capital Management's 13F filing for Q1 2019, filed 15 May 2019.